Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AWP changes not a concern to ABC

Executive Summary

Changes to average wholesale prices stemming from the settlement of a class action case against First Databank and McKesson will have no impact on AmerisourceBergen Corporation's business, the wholesaler said. "We are not involved in that at all," CEO David Yost said during a presentation Dec. 13. The proposed settlement may lead to lower AWPs for the majority of drugs (1"The Pink Sheet" Oct. 16, 2006, p. 13). ABC predicted that the impact to its customers will be limited. "If there are changes to AWP, we would expect the discounts to be adjusted accordingly and so, at the end of the day, the retailer would be adequately compensated," Yost predicted. There may be a 90-day period for the market to adjust to the new structure, but "we expect it to have no lasting impact on our customers"...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS047839

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel